MissionIR Articles
-
Pressure BioSciences Inc. (PBIO) Issues Update on Guidance for Revenue Growth and Success of Revolutionary CBD Oil Processing System
The company believes that its total revenue will more than double in 2020, led by commercialization of its revolutionary CBD oil nanoemulsification system PBIO’s BaroShear K45, based on the company’s proprietary Ultra Shear Technology (UST)…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Featured on Stock Day with Everett Jolley to Discuss Advancements in Proprietary Platforms
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its President and CEO Richard T.…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Adds Daniel J. Shea as Chief Financial Officer at Pivotal Time for Growth
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Daniel J. Shea has joined the…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and Potential Use in Clinical Diagnostics
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the publication of two scientific journal…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Agreement with Prominent Biotherapeutics Firm
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life-sciences and other industries, recently executed a contract services agreement with a well-known biotherapeutics…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Receives Two New Purchase Orders for Revolutionary BaroShear K45 Processing System
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its receipt of two additional purchase…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q2 2019 Financial Results, Provides Business Update
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q2 2019 Financial Results and Provide Business Update
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, on Tuesday announced that it will host a…
-
Pressure BioSciences Inc. (PBIO) Enters Contract Services Agreement with World-Renowned Biotherapeutics Firm
PBIO expects to achieve a significant revenue increase in 2019 and beyond through the expansion of its proprietary BaroFold platform into the estimated $44 billion global bioprocess technology market Over 200 therapeutic proteins and peptides…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Solves CBD Water-Solubility Problem with Patented UST Platform
Pressure BioSciences (OTCQB: PBIO) recently launched its BaroShear K45 system which is based on the company’s proprietary Ultra Shear Technology (“UST”) platform. The innovative system has been optimized for the unique purpose of producing high…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Provides Proprietary Benchtop UST Instrument to Ohio State Scientists
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, recently provided a working benchtop Ultra Shear Technology (“UST”)…
-
Pressure BioSciences Inc.’s (PBIO) Entry into CBD Market Aims Next-Gen Nanoemulsification Platform at Critical Water-Solubility Issues
PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces First Sale of the BaroShear K45, A Revolutionary Water-Soluble CBD Manufacturing System
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM)…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Second Major Contract Utilizing its BaroFold Technology Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Flagship Barocycler 2320EXTREME Featured at International Conference in China
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Highlighted at Spectrometry Conference
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, recently announced that its patented pressure cycling technology (“PCT”) platform was…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Launches Novel System to Revolutionize High Quality, Water-Soluble CBD Manufacturing
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, this morning announced the launch of its BaroShear(TM) K45 system based…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Achieves First Major Milestone in Potential Breakthrough Processing Method for Higher Quality, Safer Foods and Beverages
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, this morning announced the first major milestone achievement in its collaboration…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Ultra High Pressure HUB Platform Featured at World’s Largest Annual Food Science Conference
Pressure BioSciences (OTCQB: PBIO) today announced the featuring of its HUB platform of unique, ultra-high pressure instruments in three presentations at the world’s largest annual food science conference, the Institute of Food Technologists (“IFT”), held…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Prominently Featured in Record Number of ASMS Presentations
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of high pressure-based instruments, consumables, and related services for the global life sciences and other industries worldwide, today announced its patented pressure cycling technology…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option